October 7, 2011

A growing number of people with Medicare are using free preventive services provided by the Affordable Care Act, the Centers for Medicare and Medicaid Services said.

October 6, 2011

Gilead Sciences has signed an agreement with Boehringer Ingelheim to gain exclusive worldwide rights to research, develop and commercialize BI's novel anti-retroviral compounds.

October 6, 2011

German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.

October 6, 2011

A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.

October 6, 2011

Genomics has the potential to revolutionize the treatment of cancer and the drug industry, and the New York Pharma Forum is sponsoring a symposium on the subject in December.

October 5, 2011

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

October 3, 2011

Bristol-Myers Squibb will present 22 study abstracts next month at the 62nd annual meeting of the American Association for the Study of Liver Diseases in San Francisco, the company said.

October 3, 2011

Pharmacy benefit manager Express Scripts has launched a suite of services for drug makers through HealthBridge Pharma & Biotech to provide a single-solution approach to patient care.

September 29, 2011

The American Pharmacists Association is marking Pain Awareness Month by encouraging patients to talk with their pharmacists about pain and pain medications they're taking.

September 29, 2011

A "vast majority" of employers don't know how much they're spending on specialty drugs through their medical or pharmacy plans, according to a new survey by the Midwest Business Group on Health.

September 28, 2011

Sagent Pharmaceuticals has launched its new chemotherapy drug.

September 27, 2011

AmerisourceBergen on Tuesday purchased TheraCom, a subsidiary of CVS Caremark that provides a wide range of support to pharmaceutical and biotechnology drug manufacturers, including consulting and reimbursement services, for $250 million.

September 27, 2011

A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

September 26, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis in children.

September 26, 2011

The Apothecary Shops founder and CEO John Musil was named CEO of the Year among leaders of private companies at the Arizona Corporate Excellence Awards, The Apothecary Shops said Monday.

September 23, 2011

The Food and Drug Administration has approved a treatment made by Alexion Pharmaceuticals for a rare blood disorder that affects children.

September 22, 2011

A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

September 21, 2011

Generic drug maker Mylan has entered an agreement with Hoffmann La Roche concerning its version of an oral chemotherapy drug.

September 20, 2011

Wellmark Blue Cross and Blue Shield has named Hy-Vee's specialty pharmacy division its preferred provider of specialty pharmacy benefits for members, Hy-Vee said.

September 20, 2011

McKesson Specialty Health has introduced a new program that is designed to help independent, community-based oncology practices grow and deliver high-quality care to patients.

September 20, 2011

Only one stakeholder stands to gain from the proposed merger of Express Scripts and Medco — and that would be the new “mega PBM” the deal would create, not payers, and definitely not patients, either.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

September 19, 2011

A drug made by Merck for treating HIV infection was effective and tolerated in patients regardless of their gender or race, according to results of a late-stage clinical trial announced Monday.

September 16, 2011

Pharmacy benefit manager Express Scripts will provide services for patients using a drug to manage a debilitating side effect of many anti-cancer treatments, ESI said.